Narrative review synthesizes evidence on NAFLD, NASH, and viral hepatitis management without reported trial data
Your Liver Has an Immune Army — and It Can Turn Against You
This narrative review addresses management considerations for nonalcoholic fatty liver disease (NAFLD), nonalcoholic steatohepatitis (NASH),…
Your liver's own immune cells can turn on itself to cause permanent scarring, but scientists are now mapping these cells to stop the damage …
Review evaluates lactate-lactylation signaling hub targeting for dismantling tumor-driven immunosuppression and overcoming therapeutic resistance
Why Some Cancers Shrug Off Immunotherapy — and What May Change That
This review examines the lactate-lactylation signaling hub as a potential metabolic-epigenetic strategy.
Tumors use sugar-burning waste to block immune cells and resist treatment, but new therapies targeting this process could help immunotherapy…
Phase 1b trial of intravenous B001 shows favorable safety in aquaporin-4-positive NMOSD patients
A New MS-Like Disease Drug Passes Its First Human Safety Test
This Phase 1b randomized, double-blind, placebo-controlled trial evaluated intravenous B001 in 22 patients with aquaporin-4 immunoglobulin G…
A new drug for a rare nerve disease that can cause blindness and paralysis passed its first human safety test with no severe side effects se…
Narrative review explores multimodal approaches for autoimmune diseases including rheumatoid arthritis and Crohn's
Scarring From the Inside: How Your Immune System Can Turn Against Your Own Organs
This narrative review examines the integration of immune modulation, epigenetic reprogramming, and mechanobiological interventions for autoi…
Your immune system can cause permanent scarring inside organs like lungs and joints, driving autoimmune diseases such as rheumatoid arthriti…
Case report describes obinutuzumab achieving renal remission in elderly podocytopathy with B-cell disorder
A Cancer Drug Cleared a Man's Failing Kidneys — and Doctors Aren't Sure Why
This single case report details the use of obinutuzumab in a 76-year-old male with podocytopathy and a suspected B-cell lymphoproliferative …
A blood cancer drug put a 76-year-old man's failing kidneys into complete remission within one month, offering hope for elderly patients wit…
Review synthesizes current evidence without reporting specific trial data or outcomes
The Hidden Problem With Omega-3 Supplements You May Not Know
This narrative review synthesizes existing literature on a broad topic without detailing specific study populations, interventions, or outco…
One of the most important omega-3 fatty acids for your brain and heart goes rancid before it can do its job — but new encapsulation technolo…
Acupuncture with lung-large intestine theory improves asthma exacerbation outcomes versus conventional therapy
Acupuncture added to standard care improved lung function in a small asthma study
This RCT in 48 patients with acute asthma exacerbation compared acupuncture to conventional therapy.
Adding acupuncture to standard asthma care improved lung function and symptom scores in a small study of patients with acute exacerbations.
Combined albumin-lymphocyte score and skeletal muscle index linked to survival in ovarian cancer surgery patients
The Hidden Score That Could Predict Ovarian Cancer Survival
A retrospective cohort study of 347 patients with primary ovarian cancer undergoing debulking surgery found that a lower albumin-lymphocyte …
A new pre-surgery score combining blood markers and muscle mass predicts ovarian cancer survival better than either measure alone.
Systematic review examines IL-15-based immunotherapy for cancer with manageable toxicity profiles
New Immune Booster Could Help Cancer Fighters Last Longer
A systematic review evaluated IL-15-based cancer immunotherapy, including recombinant IL-15 and immunocytokines, for cancer treatment.
A new immune booster helps cancer fighters stay active longer, potentially making treatments for solid tumors and CAR-T therapy work far bet…
Spatial multi-omics technologies may advance gastric cancer precision medicine by overcoming limitations of conventional methods
Stomach Cancer Has a Hidden Map. Scientists Are Finally Reading It
A systematic review examines spatial multi-omics technologies integrating genomics, transcriptomics, proteomics, and metabolomics with high-…
New tools finally reveal exactly where stomach cancer cells hide and how they talk, paving the way for more precise therapies for patients w…
Systematic review examines immune checkpoint inhibitors, innate immunity, and immune-related adverse events in cancer patients
A review suggests innate immunity plays a key role in cancer drug side effects
This systematic review evaluated immune checkpoint inhibitors (ICIs) in patients with cancer, focusing on immune-related adverse events (irA…
Cancer drugs that help fight tumors can also cause serious inflammation, and new research shows the body's first line of defense plays a key…
Systematic review evaluates anti-IL-5 and anti-IL-5Rα biologics for eosinophilic respiratory and systemic diseases
New Asthma Drugs Target the Real Troublemakers Hiding in Your Lungs
This systematic review examined the use of anti-IL-5 and anti-IL-5Rα biologics in patients with severe eosinophilic asthma, chronic rhinosin…
New asthma drugs target the specific immune cells causing swelling and mucus in severe asthma, nasal polyps, and rare eosinophil diseases.